Trim MMM 15-20% to 80-85% benchmark weight on four aligned bearish signals; stop at $169
Underweight rating justified based on four aligned bearish signals exceeding the 8/26/8/27 empirical setups (three signals, histogram -0.96) where Hold produced -1.3% alpha leakage and Underweight produced -2.3% alpha. The 15-20% trim sizing at the lower end of the calibrated band honors the 8/27 lesson that drift-mode realizations reliably produce noise-level alpha capture eaten by execution drag at larger sizes. The structural floor (Q2 2026 inflection: +29% YoY net income, +33% YoY EPS, OCF swing from -$954M to +$986M) and litigation progress prevent a larger trim or Sell rating, while the four aligned bearish signals and catalyst vacuum warrant modest directional lean over Hold passivity.
| Position | Action |
|---|---|
| Four aligned bearish signals present (Bollinger breach at $175.58, price $4 below 10 EMA at $178.43, MACD histogram at -1.23, ATR range expansion 6.27 vs 3.66) | Trim 15-20% of existing MMM exposure at $174.34, resulting in ~80-85% benchmark weight |
| Close below $169.00 on volume >3M (50 SMA structural break confirmed) | Trim residual toward 50% of benchmark weight, reassess at $159.40 (200 SMA test) |
| Q3 2026 earnings miss on EPS or revenue | Move to Sell rating |
| Adverse litigation headline with cash charge >$200M | Immediate 30% reduction |
| Close above $190 absent earnings confirmation | Trim 15% to monetize extended breakout |
3M is a buy on this pullback because the earnings recovery is underway (Q2 EPS +33% YoY, 74% forward rebound expected), the technical setup represents a healthy mean-reversion rather than breakdown, and macro tailwinds (falling oil, stable rates, low recession risk) are precisely aligned to drive margin expansion.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | 170.38 | neutral |
| close_200_sma | 159.40 | neutral |
| close_10_ema | 178.43 | bearish |
| rsi | 45.32 | neutral |
| macd | 1.93 | bearish |
| macd_signal | 3.16 | bearish |
| macdh | -1.23 | bearish |
| boll | 179.86 | neutral |
| boll_ub | 184.14 | neutral |
| boll_lb | 175.58 | bearish |
| atr | 3.66 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Re-add to benchmark weight (100%), monitor for upgrade toward Overweight
Earnings recovery is underway and will drive valuation re-rating
EV: ~+11% (conservative DCF fair value); potential +6-9% to $185-190 on tactical bounce
MMM is not a buy-the-dip opportunity but rather a stock in coordinated technical breakdown with earnings that are fundamentally over-promised, a balance sheet that is structurally impaired by debt-funded buybacks, and structural risks including PFAS litigation, a 53% dividend cut precedent, and FCF that cannot sustain current capital return levels.
· concedes: The 8% recession probability is a constructive macro backdrop; MMM's 90-day return of +17.76% suggests some recovery is priced in, but the asymmetry is negative: if recession odds rise to 20%, MMM's beta of 1.08 means it gets hit at least as hard as the market
→ vs conservative: MACD crossover is a lagging indicator confirming a $4 move within a $15 range, not a regime change; decelerating histogram suggests momentum exhaustion forming reversal, not continuation
→ vs neutral: Waiting for 50 SMA retest with MACD bullish re-cross is a lagging confirmation strategy that systematically sacrifices 6-8% upside on every successful re-test and misses first 30-40% of upward moves
→ vs conservative: Flush to $155-$160 from current levels requires 8-11% additional decline, which would obliterate golden cross and confirm regime change, flipping the entry thesis entirely rather than creating opportunity
| close | 174.34 | neutral |
| volume | 2,335,571 | neutral |
Support: 175.58 · 170.38 · 159.4 | Resistance: 178.43 · 179.86 · 182.98 · 184.14
MMM trades in a constructive long-term regime with the golden cross intact (50 SMA 170.38 above 200 SMA 159.40), but faces short-term headwinds: price at 174.34 closed below the lower Bollinger Band (175.58) and MACD has confirmed a bearish crossover (MACD 1.93 below Signal 3.16). RSI has cooled from overbought (69.70 on Aug 12) to neutral (45.32), and the 10 EMA at 178.43 has rolled over, signaling momentum deterioration. The critical support level is the 50 SMA at 170.38; a break below it on elevated volume (>3M) would invalidate the medium-term uptrend, while holding it sets up a potential bounce retest of the 10 EMA. ATR has eased to 3.66 (from 4.99 on Jul 28), though intraday volatility expanded to 6.27, suggesting larger swings ahead. The verdict is HOLD with tactical bullish bias contingent on defending the 50 SMA.
Market Cap
$89.9 billion
Ticker
MMM
Diluted Shares Outstanding
~522.4M
Current Price
~$172
P/E (TTM)
30.97
Forward P/E
17.83
PEG Ratio
1.80
Price / Book
30.46
EPS (TTM)
$5.63
Forward EPS
$9.78
Book Value
$5.72
Dividend Yield
1.74%
Beta
1.08
52-Week Range
$139.34 – $184.90
Revenue (TTM)
$25.18B
Gross Profit
$9.923B
EBITDA
$6.488B
Operating Income
$5.124B
Net Income
$3.00B
ROE
81.9%
ROA
8.7%
Total Assets
$34.92B
Total Liabilities
$31.92B
Stockholders' Equity
$2.95B
Net Debt
$9.60B
Total Debt
$12.55B
Current Ratio
1.24
Debt/Equity
437.9%
Tangible Book Value
-$4.475 billion
Treasury Stock
$38.18B
Gains/Losses not affecting RE
-$5.05B
Annual Interest Expense
~$946M
FCF 2025
$1.40B
FCF 2024
$0.64B
FCF 2023
$5.07B
FCF 2022
$3.84B
FCF Q1 2026
$349M
FCF Q2 2026
$763M
Buybacks 2025
$3.25B
Buybacks 2024
$1.80B
Dividends 2025
$1.56B
Operating CF 2025
$2.31B
Revenue 2022
$26.16B
Revenue 2023
$24.61B
Revenue 2024
$24.58B
Revenue 2025
$24.95B
Net Income 2022
$5.78B
Net Income 2023
-$7.00B
Net Income 2024
$4.17B
Net Income 2025
$3.25B
Diluted EPS 2022
$10.18
Diluted EPS 2023
-$12.63
Diluted EPS 2024
$7.55
Diluted EPS 2025
$6.00
Q2 2025 Revenue
$6.34B
Q2 2025 Operating Income
$1.14B
Q2 2025 Net Income
723M
Q2 2025 Diluted EPS
$1.34
Q3 2025 Revenue
$6.52B
Q3 2025 Operating Income
$1.61B
Q3 2025 Net Income
834M
Q3 2025 Diluted EPS
$1.55
Q4 2025 Revenue
$6.13B
Q4 2025 Operating Income
$0.80B
Q4 2025 Net Income
577M
Q4 2025 Diluted EPS
$1.07
Q1 2026 Revenue
$6.03B
Q1 2026 Operating Income
$1.40B
Q1 2026 Net Income
653M
Q1 2026 Diluted EPS
$1.23
Q2 2026 Revenue
$6.50B
Q2 2026 Operating Income
$0.98B
Q2 2026 Net Income
933M
Q2 2026 Diluted EPS
$1.78
Q2 2026 Operating Cash Flow
986M
Total Returned 2025
$4.81B
Q1 2026 Capital Returned
$2.41B
Q2 2026 Capital Returned
$1.40B
50-day MA
$170.74
200-day MA
$160.83
Net Debt 2022
$12.28B
Net Debt 2023
$10.30B
Net Debt 2024
$7.44B
Net Debt 2025
$7.37B
Net Debt Q2 2026
$9.60B
Strengths
Concerns
HOLD
Macro: Fed is expected to hold steady through year-end 2026 (0 cuts priced at 89% on Polymarket), supporting rate-sensitive cyclicals. US recession probability is just 8%, consistent with a soft-landing or no-landing scenario. WTI crude at $90 in August is priced at only 4% (down sharply from 58% a week prior), providing tailwind for MMM's petroleum-derived inputs. Gold settling lower implies stable-rate regime is weighing on inflation-hedge commodities.